openPR Logo
Press release

Migraine Drugs Market to Register a Healthy 3.50% CAGR between 2017 and 2025

02-05-2019 08:30 PM CET | Health & Medicine

Press release from: Transparency Market Research

Migraine Drugs Market to Register a Healthy 3.50% CAGR between

The global migraine drugs market is highly competitive and consolidated due to presence of strong players, finds Transparency Market Research (TMR). Some of the key players operating in the global migraine drugs market. Some of the leading players in the global migraine drugs market includes AstraZeneca Plc., Pfizer, Inc., Allergan Plc., Teva Pharmaceutical Industries Ltd., Eli Lilly & Co., GlaxoSmithKline plc, Novartis AG, Valeant Pharmaceutical International, Inc., Merck & Co., Inc., Janssen Pharmaceutical Company, Zosano Pharma Corporation, Endo Pharmaceuticals Inc., Avanir Pharmaceuticals, Inc., Alder BioPharmaceuticals Inc., and Eisai Co., Ltd. The players in market are increasingly investing on the research and development (R&D) activities for product improvement and new product developments owing to numerous unmet demands from consumers.

Read Report Overview:
https://www.transparencymarketresearch.com/migraine-drugs-market.html

TMR anticipated the global revenue of the global migraine drugs market was registered of US$2.72 bn in 2016 and with a CAGR of 3.5% over the forecast period from 2017 to 2025 is expected to attain a value of US$3.72 bn by the end of 2025. North America has accounted for larger share in the market owing to presence of the higher healthcare facilities and availability of specialty migraine drugs in the region. Over the forecast period, North America is projected to account for leading share and attain the value of US$2.13 bn by the end of 2025. The abortive treatment type, triptans are dominating the market with larger share.

Perceive the Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31136

The World Health Organization (WHO) states that migraine is a common disease which is commonly found in the 14.7% of the world population. The risk of chronic condition such as migraine is 2 to3 time higher in females owing to the changes in estrogen levels in females mainly in the menstruation period. Consumption of drugs such as contraceptives and hormones replacement drugs and therapies which carries the hormonal changes in the women are boosting the migraine prevalence in women. The rising population especially growing female population globally is boosting growth of the global migraine drugs market.

Rising awareness about the availability of the migraine treatment is another factor influencing the growth of the global migraine drugs market. However, some developing countries are unaware of migraine its effects and treatment, to increase awareness levels in these regions, numerous government and the organizations such as Migraine Association and American Headache are taking efforts to increase awareness about the diseases and numerous headache disorders. The aforementioned factors are propelling growth of the global migraine drugs market.

Obtain the Brochure of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31136

However, risk of possible side effects associated with high consumption of migraine drugs is a key factor hampering growth of the market. Additionally, easy availability of generics medicines and reliance on over the counter (OTC) pain killers mainly in developing and under developed countries are crimping growth of the global migraine drugs market. Nevertheless, manufacturing companies of migraine drugs exhibits high safety and efficiency of drugs. For acheiveing desiranble results and safety these companies are increasingly investing on the development and improving drugs which is creating lucrative opportunities in the market for key players and new entrants. Additionally, approval from the US food and drugs administration (FDA) is stimulating the adoption of these drugs which possess high potential opportunities for growth in the market.

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: aman.j@tmr.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Migraine Drugs Market to Register a Healthy 3.50% CAGR between 2017 and 2025 here

News-ID: 1562693 • Views: 505

More Releases from Transparency Market Research

Potassium Bicarbonate Market Technological breakthroughs, Value chain and stakeh …
Overview TMR’s report on the Potassium Bicarbonate Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Potassium Bicarbonate serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Potassium Bicarbonate over the forecast period. These indicators help businesses
Liquid Analytical Instruments Market Global Market Opportunity Assessment Study …
Overview TMR’s report on the Liquid Analytical Instruments Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Liquid Analytical Instruments serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Liquid Analytical Instruments over the forecast period. These
Boron Oxide Market Growth Prospects, Trends and Forecast up to 2023
Overview TMR’s report on the Boron Oxide Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Boron Oxide serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Boron Oxide over the forecast period. These indicators help businesses
Hydrochloric Acid Market to Witness a Pronounce Growth During 2016 - 2024
Overview TMR’s report on the Hydrochloric Acid Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Hydrochloric Acid serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Hydrochloric Acid over the forecast period. These indicators help businesses

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Clomifene Citrate Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Clomifene Citrate Market" across the global, regional and country level. The report provides 360° analysis of "Clomifene Citrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Clomifene Citrate industry, and estimates the future trend of Clomifene Citrate market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business